<VariationArchive VariationID="584232" VariationName="NC_000002.12:g.(?_25234259)_(25345952_?)del" VariationType="Deletion" Accession="VCV000584232" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2018-10-10" MostRecentSubmission="2018-10-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="557489" VariationID="584232">
      <GeneList>
        <Gene Symbol="LOC129933290" FullName="ATAC-STARR-seq lymphoblastoid active region 15445" GeneID="129933290" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25275439" stop="25275658" display_start="25275439" display_stop="25275658" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933291" FullName="ATAC-STARR-seq lymphoblastoid silent region 11252" GeneID="129933291" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25286827" stop="25286876" display_start="25286827" display_stop="25286876" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="DNMT3A" FullName="DNA methyltransferase 3 alpha" GeneID="1788" HGNC_ID="HGNC:2978" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25227874" stop="25342590" display_start="25227874" display_stop="25342590" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25455829" stop="25565458" display_start="25455829" display_stop="25565458" Strand="-" />
          </Location>
          <OMIM>602769</OMIM>
          <Haploinsufficiency last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC122756673" FullName="Sharpr-MPRA regulatory region 14395" GeneID="122756673" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25295080" stop="25295775" display_start="25295080" display_stop="25295775" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933287" FullName="ATAC-STARR-seq lymphoblastoid silent region 11248" GeneID="129933287" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25251259" stop="25251328" display_start="25251259" display_stop="25251328" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933288" FullName="ATAC-STARR-seq lymphoblastoid silent region 11249" GeneID="129933288" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25252059" stop="25252278" display_start="25252059" display_stop="25252278" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933289" FullName="ATAC-STARR-seq lymphoblastoid silent region 11250" GeneID="129933289" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25252449" stop="25252598" display_start="25252449" display_stop="25252598" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933292" FullName="ATAC-STARR-seq lymphoblastoid active region 15446" GeneID="129933292" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25294678" stop="25294797" display_start="25294678" display_stop="25294797" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933293" FullName="ATAC-STARR-seq lymphoblastoid silent region 11253" GeneID="129933293" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25340648" stop="25340767" display_start="25340648" display_stop="25340767" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933294" FullName="ATAC-STARR-seq lymphoblastoid silent region 11254" GeneID="129933294" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25341048" stop="25341287" display_start="25341048" display_stop="25341287" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933295" FullName="ATAC-STARR-seq lymphoblastoid silent region 11255" GeneID="129933295" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25341388" stop="25341557" display_start="25341388" display_stop="25341557" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933296" FullName="ATAC-STARR-seq lymphoblastoid silent region 11256" GeneID="129933296" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25341848" stop="25342057" display_start="25341848" display_stop="25342057" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933297" FullName="ATAC-STARR-seq lymphoblastoid silent region 11257" GeneID="129933297" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25342118" stop="25342597" display_start="25342118" display_stop="25342597" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129933298" FullName="ATAC-STARR-seq lymphoblastoid active region 15447" GeneID="129933298" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25342718" stop="25342837" display_start="25342718" display_stop="25342837" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MIR1301" FullName="microRNA 1301" GeneID="100302246" HGNC_ID="HGNC:35253" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25328640" stop="25328721" display_start="25328640" display_stop="25328721" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_25234259)_(25345952_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" innerStart="25234259" innerStop="25345952" display_start="25234259" display_stop="25345952" variantLength="111694" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="25457128" innerStop="25568821" display_start="25457128" display_stop="25568821" variantLength="111694" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.(?_25234259)_(25345952_?)del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.(?_25234259)_(25345952_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_25457128)_(25568821_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_25457128)_(25568821_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_25234259)_(25345952_?)del AND Tatton-Brown-Rahman overgrowth syndrome" Accession="RCV000708407" Version="2">
        <ClassifiedConditionList TraitSetID="16415">
          <ClassifiedCondition DB="MedGen" ID="C4014545">Tatton-Brown-Rahman overgrowth syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-06-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2018-10-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="16415" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21246" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tatton-Brown-rahman syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tall stature-intellectual disability-facial dysmorphism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tatton-Brown-Rahman overgrowth syndrome</ElementValue>
                <XRef ID="MONDO:0014382" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TBRS</ElementValue>
                <XRef Type="MIM" ID="615879" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Tatton-Brown-Rahman syndrome (TBRS) is an overgrowth / intellectual disability syndrome characterized by length/height and/or head circumference ≥2 SD above the mean for age and sex, obesity / increased weight, intellectual disability that ranges from mild to severe, joint hypermobility, hypotonia, behavioral/psychiatric issues, kyphoscoliosis, and seizures. Individuals with TBRS have subtle dysmorphic features, including a round face with coarse features, thick horizontal low-set eyebrows, narrow (as measured vertically) palpebral fissures, and prominent upper central incisors. The facial gestalt is most easily recognizable in the teenage years. TBRS may be associated with an increased risk of developing acute myeloid leukemia. There are less clear associations with aortic root dilatation and increased risk of other hematologic and solid tumors.</Attribute>
                <XRef ID="NBK581652" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17674" />
                <XRef ID="17674" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35771960</ID>
                <ID Source="BookShelf">NBK581652</ID>
              </Citation>
              <XRef ID="404443" DB="Orphanet" />
              <XRef ID="C4014545" DB="MedGen" />
              <XRef ID="MONDO:0014382" DB="MONDO" />
              <XRef Type="MIM" ID="615879" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1609543" SubmissionDate="2018-08-29" DateLastUpdated="2018-10-10" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4275121|MedGen:C4014545" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000837517" DateUpdated="2018-10-10" DateCreated="2018-10-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the DNMT3A gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. A similar deletion of DMT3A, which included additional genes, has been observed in an individual affected with Tatton-Brown-Rahman syndrome (PMID:Â¬â€ 26866722). Loss-of-function variants in DNMT3A are known to be pathogenic (PMID: 24614070). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNMT3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_25457128)_(25568821_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Tatton-Brown-rahman syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C4014545" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1609543" TraitType="Disease" MappingType="Name" MappingValue="Tatton-Brown-rahman syndrome" MappingRef="Preferred">
        <MedGen CUI="C4014545" Name="Tatton-Brown-Rahman overgrowth syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

